Skip navigation

Belladonna


What is it?

Belladonna is a plant. The leaf and root are used to make medicine.

The name “belladonna” means “beautiful lady,” and was chosen because of a risky practice in Italy. The belladonna berry juice was used historically in Italy to enlarge the pupils of women, giving them a striking appearance. This was not a good idea, because belladonna can be poisonous.

Though widely regarded as unsafe, belladonna is used as a sedative, to stop bronchial spasms in asthma and whooping cough, and as a cold and hay fever remedy. It is also used for Parkinson's disease, colic, motion sickness, and as a painkiller.

Belladonna is used in ointments that are applied to the skin for joint pain (rheumatism), leg pain caused by a disc in the backbone pushing on the sciatic nerve (sciatica), and nerve pain (neuralgia). Belladonna is also used in plasters (medicine-filled gauze applied to the skin) for treating psychiatric disorders, a behavior disorder called hyperkinesis, excessive sweating (hyperhidrosis), and bronchial asthma.

Rectally, belladonna is used in hemorrhoid suppositories.

How effective is it?

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.

The effectiveness ratings for BELLADONNA are as follows:

Insufficient evidence to rate effectiveness for...

  • Asthma.
  • Whooping cough.
  • Colds.
  • Hay fever.
  • Parkinson's disease.
  • Motion sickness.
  • Arthritis-like pain.
  • Nerve problems.
  • Hemorrhoids.
  • Spasms and colic-like pain in the stomach and bile ducts.
  • Other conditions.
More evidence is needed to rate the effectiveness of belladonna for these uses.

How does it work?

Return to top
Belladonna has chemicals that can block functions of the body's nervous system. Some of the bodily functions regulated by the nervous system include salivation, sweating, pupil size, urination, digestive functions, and others.

Are there safety concerns?

Return to top
Belladonna is UNSAFE when taken by mouth. It contains chemicals that can be toxic.

Side effects can include dry mouth, enlarged pupils, blurred vision, red dry skin, fever, fast heartbeat, inability to urinate or sweat, hallucinations, spasms, mental problems, convulsions, and coma.

Special precautions & warnings:

Pregnancy and breast-feeding: Belladonna is UNSAFE when taken by mouth during pregnancy. Belladonna contains potentially toxic chemicals and has been linked to reports of serious side effects. Belladonna is also UNSAFE during breast-feeding. It can reduce milk production and also passes into breast milk.

Congestive heart failure (CHF): Belladonna might cause rapid heartbeat (tachycardia) and might make CHF worse.

Constipation: Belladonna might make constipation worse.

Down syndrome: People with Down syndrome might be extra-sensitive to the potentially toxic chemicals in belladonna and their harmful effects.

Esophageal reflux: Belladonna might make esophageal reflux worse.

Fever: Belladonna might increase the risk of overheating in people with fever.

Stomach ulcers: Belladonna might make stomach ulcers worse.

Gastrointestinal (GI) tract infections: Belladonna might slow emptying of the intestine, causing retention of bacteria and viruses that can cause infection.

Gastrointestinal (GI) tract blockage: Belladonna might make obstructive GI tract diseases (including atony, paralytic ileus, and stenosis) worse.

Hiatal hernia: Belladonna might make hiatal hernia worse.

Narrow-angle glaucoma: Belladonna might make narrow-angle glaucoma worse.

Rapid heartbeat (tachycardia): Belladonna might make rapid heartbeat worse.

Ulcerative colitis: Belladonna might promote complications of ulcerative colitis.

Difficulty urinating (urinary retention): Belladonna might make this urinary retention worse.

Are there interactions with medications?

Return to top

Moderate

Be cautious with this combination.

Drying medications (Anticholinergic drugs)
Belladonna contains chemicals that cause a drying effect. It also affects the brain and heart. Drying medications called anticholinergic drugs can also cause these effects. Taking belladonna and drying medications together might cause side effects including dry skin, dizziness, low blood pressure, fast heart beat, and other serious side effects.

Some of these drying medications include atropine, scopolamine, and some medications used for allergies (antihistamines), and for depression (antidepressants).

Are there interactions with herbs and supplements?

Return to top
There are no known interactions with herbs and supplements.

Are there interactions with foods?

Return to top
There are no known interactions with foods.

What dose is used?

Return to top
The appropriate dose of belladonna depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for belladonna. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

Other names

Return to top
Atropa belladonna, Atropa acuminata, Baccifère, Belladona, Belladone, Belle-Dame, Belle-Galante, Bouton Noir, Cerise du Diable, Cerise Enragée, Cerise d’Espagne, Deadly Nightshade, Devil's Cherries, Devil's Herb, Divale, Dwale, Dwayberry, Grande Morelle, Great Morel, Guigne de la Côte, Herbe à la Mort, Herbe du Diable, Indian Belladonna, Morelle Furieuse, Naughty Man's Cherries, Poison Black Cherries, Suchi.

Methodology

Return to top
To learn more about how this article was written, please see the Natural Medicines Comprehensive Database methodology.methodology (http://www.nlm.nih.gov/medlineplus/druginfo/natural/methodology.html).

References

Return to top
To see all references for the Belladonna page, please go to http://www.nlm.nih.gov/medlineplus/druginfo/natural/531.html.

  1. Golwalla A. Multiple extrasystoles: an unusual manifestation of belladonna poisoning. Dis Chest 1965;48:83-84.
  2. Hamilton M and Sclare AB. Belladonna poisoning. Br Med J 1947;611-612.
  3. Cummins BM, Obetz SW, Wilson MR, and et al. Belladonna poisoning as a facet of psychodelia. Jama 1968;204:153.
  4. Sims SR. Poisoning due to belladonna plasters. Br Med J 1954;1531.
  5. Minors EH. Five cases of belladonna poisoning. Br Med J 1948;2:518-519.
  6. Joll ME. Three cases of belladonna poisoning. Lancet 1916;2:647.
  7. Firth D and Bentley JR. Belladonna poisoning from eating rabbit. Lancet 1921;2:901.
  8. Bergmans M, Merkus J, Corbey R, and et al. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987;9:227-234.
  9. Lichstein, J. and Mayer, J. D. Drug therapy in the unstable bowel (irritable colon). A 15-month double-blind clinical study in 75 cases of response to a prolonged-acting belladonna alkaloid-phenobarbital mixture or placebo. J.Chron.Dis. 1959;9:394-404.
  10. Steele CH. The use of Bellergal in the prophylactic treatment of some types of headaches. Ann Allergy 1954;42-46.
  1. Myers, J. H., Moro-Sutherland, D., and Shook, J. E. Anticholinergic poisoning in colicky infants treated with hyoscyamine sulfate. Am J Emerg.Med 1997;15:532-535. View abstract.
  2. Whitmarsh, T. E., Coleston-Shields, D. M., and Steiner, T. J. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 1997;17:600-604. View abstract.
  3. Friese K, Kruse S, Ludtke R, and et al. The homoeopathic treatment of otitis media in children--comparisons with conventional therapy. Int.J Clin Pharmacol Ther. 1997;35:296-301. View abstract.
  4. Ceha LJ, Presperin C, Young E, and et al. Anticholinergic toxicity from nightshade berry poisoning responsive to physostigmine. The Journal of Emergency Medicine 1997;15:65-69. View abstract.
  5. Schneider, F., Lutun, P., Kintz, P., Astruc, D., Flesch, F., and Tempe, J. D. Plasma and urine concentrations of atropine after the ingestion of cooked deadly nightshade berries. J Toxicol Clin Toxicol 1996;34:113-117. View abstract.
  6. Walach, H. Does a highly diluted homoeopathic drug act as a placebo in healthy volunteers? Experimental study of Belladonna 30C in double-blind crossover design--a pilot study. J.Psychosom.Res. 1993;37:851-860. View abstract.
  7. Trabattoni G, Visintini D, Terzano GM, and et al. Accidental poisoning with deadly nightshade berries: a case report. Human Toxicol. 1984;3:513-516. View abstract.
  8. Pentel P and Mikell F. Reaction to phenylpropalamine/chlorpheniramine/belladonna compound in a women with unrecognised autonomic dysfunction. Lancet 7-31-1982;2:274. View abstract.
  9. Eichner ER, Gunsolus JM, and Powers JF. "Belladonna" poisoning confused with botulism. Jama 8-28-1967;201:695-696. View abstract.
  10. Goldsmith SR, Frank I, and Ungerleider JT. Poisoning from ingestion of a stramonium-belladonna mixture: flower power gone sour. J.A.M.A 4-8-1968;204:169-170. View abstract.
  11. Gabel MC. Purposeful ingestion of belladonna for hallucinatory effects. J.Pediatr. 1968;72:864-866. View abstract.
  12. Lance, J. W., Curran, D. A., and Anthony, M. Investigations into the mechanism and treatment of chronic headache. Med.J.Aust. 11-27-1965;2:909-914. View abstract.
  13. Dobrescu DI. Propranolol in the treatment of disturbances of the autonomic nervous system. Curr.Ther.Res Clin Exp 1971;13:69-73. View abstract.
  14. King, J. C. Anisotropine methylbromide for relief of gastrointestinal spasm: double- blind crossover comparison study with belladonna alkaloids and phenobarbital. Curr.Ther Res Clin.Exp 1966;8:535-541. View abstract.
  15. Jacobs, K. W. Asthmador: a legal hallucinogen. Int J Addict 1974;9:503-512. View abstract.
  16. Shader RI and Greenblatt DJ. Uses and toxicity of belladonna alkaloids and synthetic anticholinergics. Seminars in Psychiatry 1971;3:449-476. View abstract.
  17. Rhodes, J. B., Abrams, J. H., and Manning, R. T. Controlled clinical trial of sedative-anticholinergic drugs in patients with the irritable bowel syndrome. J.Clin.Pharmacol. 1978;18:340-345. View abstract.
  18. Robinson, K., Huntington, K. M., and Wallace, M. G. Treatment of the premenstrual syndrome. Br.J.Obstet.Gynaecol. 1977;84:784-788. View abstract.
  19. Stieg, R. L. Double-blind study of belladonna-ergotamine-phenobarbital for interval treatment of recurrent throbbing headache. Headache 1977;17:120-124. View abstract.
  20. Ritchie, J. A. and Truelove, S. C. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J 2-10-1979;1:376-378. View abstract.
  21. Williams HC and du Vivier A. Belladonna plaster--not as bella as it seems. Contact Dermatitis 1990;23:119-120. View abstract.
  22. Kahn A., Rebuffat E, Sottiaux M, and et al. Prevention of airway obstructions during sleep in infants with breath- holding spells by means of oral belladonna: a prospective double-blind crossover evaluation. Sleep 1991;14:432-438. View abstract.
  23. Davidov, M. I. [Factors predisposing to acute urine retention in patients with prostatic adenoma]. Urologiia. 2007;:25-31. View abstract.
  24. Tsiskarishvili, N. V. and Tsiskarishvili, TsI. [Colorimetric determination of eccrine sudoriferous glands functional condition in case of hyperhidrosis and their correction by belladonna]. Georgian.Med News 2006;:47-50. View abstract.
  25. Pan, S. Y. and Han, Y. F. Comparison of the inhibitory efficacy of four belladonna drugs on gastrointestinal movement and cognitive function in food-deprived mice. Pharmacology 2004;72:177-183. View abstract.
  26. Bettermann, H., Cysarz, D., Portsteffen, A., and Kummell, H. C. Bimodal dose-dependent effect on autonomic, cardiac control after oral administration of Atropa belladonna. Auton.Neurosci. 7-20-2001;90(1-2):132-137. View abstract.
  27. Walach, H., Koster, H., Hennig, T., and Haag, G. The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment. J.Psychosom.Res. 2001;50:155-160. View abstract.
  28. Heindl, S., Binder, C., Desel, H., Matthies, U., Lojewski, I., Bandelow, B., Kahl, G. F., and Chemnitius, J. M. [Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]. Dtsch Med Wochenschr 11-10-2000;125:1361-1365. View abstract.
  29. Southgate, H. J., Egerton, M., and Dauncey, E. A. Lessons to be learned: a case study approach. Unseasonal severe poisoning of two adults by deadly nightside (Atropa belladonna). Journal of the Royal Society of Health 2000;120:127-130. View abstract.
  30. Berney, C. and Wolfensberger, T. J. [Mydriasis induced by splinter from belladonna bush]. Klin Monatsbl.Augenheilkd. 2000;216:346-347. View abstract.
  31. Balzarini, A., Felisi, E., Martini, A., and De Conno, F. Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopath J 2000;89:8-12. View abstract.
  32. Goodyear K., Lewith G., and Low JL. Randomized double-blind placebo-controlled trial of homoeopathic 'proving' for Belladonna C30. J.R.Soc.Med. 1998;91:579-582. View abstract.
  33. Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98. View abstract.
  34. McKevoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  35. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
  36. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
  37. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
Show more references
Show fewer references
Last reviewed - 09/13/2011




Page last updated: 27 October 2014